|
Jun 24
|
J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD
|
|
Jun 24
|
MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal
|
|
Jun 24
|
Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?
|
|
Jun 24
|
5 Dividend Stocks Poised to Profit From the AI Efficiency Boom
|
|
Jun 24
|
J&J introduces disposable contact lens for astigmatism and presbyopia
|
|
Jun 23
|
Compass’s Psychedelic Drug to Treat Depression Meets Goal in Trial
|
|
Jun 23
|
J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?
|
|
Jun 23
|
J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications
|
|
Jun 23
|
Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM
|
|
Jun 23
|
IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC)
|
|
Jun 23
|
Zacks Investment Ideas feature highlights: Jabil, Apple, Amazon, Johnson & Johnson and Ericsson
|
|
Jun 21
|
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
|
|
Jun 21
|
JNJ’s Consistent Payout Makes It a Top Pick for Down Markets
|
|
Jun 20
|
IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant
|
|
Jun 19
|
Johnson & Johnson (NYSE:JNJ) Faces US$8 Million Verdict Over Talcum Powder Cancer Case
|
|
Jun 19
|
J&J MedTech introduces new plates for VOLT fracture management platform
|
|
Jun 18
|
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
|
|
Jun 18
|
Johnson & Johnson rolls out TECNIS Odyssey IOL in selected regions
|
|
Jun 18
|
2 Dividend Stocks to Buy and Never Sell
|
|
Jun 18
|
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)
|